Paired comparison of efficacy 2-CdA monotherapy with CC and CMC regimens
Response . | 2-CdA vs CC, % (P) . | 2-CdA vs CMC, % (P) . |
|---|---|---|
| CR | 21/29 (.08) | 21/36 (.004) |
| CR with negative MRD | 14/20 (.18) | 14/23 (.042) |
| ORR | 78/83 (.1) | 79/80 (.4) |
Response . | 2-CdA vs CC, % (P) . | 2-CdA vs CMC, % (P) . |
|---|---|---|
| CR | 21/29 (.08) | 21/36 (.004) |
| CR with negative MRD | 14/20 (.18) | 14/23 (.042) |
| ORR | 78/83 (.1) | 79/80 (.4) |
CR indicates complete response; MRD, minimal residual disease; ORR, overall response rate.